Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 4
  • 7
  • 7

Found 7 Alcoholism trials

A listing of Alcoholism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder.

General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder.

18-75 years
Healthy Volunteer
All genders
The goal is to conduct a screening procedure to be used in evaluating individuals either with or without an alcohol use disorder (AUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, genetic study, or other research protocol that matches their …
 Research Study on Whether a Combination of 2 Medicines  Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether a Combination of 2 Medicines Works in People With Non-alcoholic Steatohepatitis (NASH)

18-99 years
All genders
This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non alcoholic steatohepatitis (NASH). NNC0194-0499 is a new medicine which works in the liver. Semaglutide is a well-known medicine, which is already used by doctors to …
 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

18-99 years
All genders
Phase 3
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study …
 Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

18-65 years
All genders
Phase 4
This study is being conducted to compare the effects of a medication (extended-release naltrexone or XR-NTX) or placebo (an inactive substance) together with brief counseling on reducing or stopping drinking.   XR-NTX is approved by the U.S. Food and Drug Administration (FDA) for treating alcohol dependence. Its use is experimental …

Effects of Nutritional Ketosis on Alcohol Metabolism

21-50 years
Healthy Volunteer
All genders
The research study is being conducted to better understand the effects of ketosis on brain functioning after three separate 3-day dietary interventions and the acute effects of alcohol during three separate MRI and lab visits after consuming about 4-5 alcohol beverages.

A Randomized Double-blind Placebo-Controlled Study of Ibudilast for Treating Alcohol Use Disorder

18-99 years
All genders
Phase 2
Interventional
The goal of this is to evaluate the safety and effectiveness of the drug Ibudilast compared to placebo (an inactive pill) in reducing the number of drinking days and the amount of alcohol consumed by people who want to stop or reduce their drinking. Study duration 11 weeks and includes …
 Imaging inflammation in individuals with Alcohol Use Disorder: an [18F]NOS study

Imaging inflammation in individuals with Alcohol Use Disorder: an [18F]NOS study

18-65 years
Healthy Volunteer
All genders
This is a research study for people ages 18-65 to learn more about how regular alcohol use affects inflammation in the brain and other organs. We will study this using a Positron Emission Tomography (PET/CT) scan using a radioactive imaging drug called [18F]NOS. [18F]NOS is an experimental radioactive molecule used …